SG3 Management’s Verve Therapeutics VERV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2022
Q4
Sell
-4,000
Closed -$137K 192
2022
Q3
$137K Buy
+4,000
New +$137K 0.02% 51